US HB19 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Republican 148-0)
Status: Introduced on December 9 2019 - 25% progression, died in committee
Action: 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Pending: House Subcommittee on Antitrust, Commercial, and Administrative Law Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, modifies certain authorities and requirements under the Medicaid Drug Rebate Program, revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and establishes several reporting requirements for drug manufacturers with respect to drug prices.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Lower Costs, More Cures Act of 2019

Sponsors

Rep. Greg Walden [R-OR]Rep. Kevin Brady [R-TX]Rep. Virginia Foxx [R-NC]Rep. Doug Collins [R-GA]
Rep. Michael Burgess [R-TX]Rep. Devin Nunes [R-CA]Rep. Tim Walberg [R-MI]Rep. James Sensenbrenner [R-WI]
Rep. Steve Scalise [R-LA]Rep. Liz Cheney [R-WY]Rep. Fred Upton [R-MI]Rep. John Shimkus [R-IL]
Rep. Robert Latta [R-OH]Rep. Brett Guthrie [R-KY]Rep. Cathy McMorris Rodgers [R-WA]Rep. Pete Olson [R-TX]
Rep. David McKinley [R-WV]Rep. Adam Kinzinger [R-IL]Rep. Morgan Griffith [R-VA]Rep. Gus Bilirakis [R-FL]
Rep. Bill Johnson [R-OH]Rep. Billy Long [R-MO]Rep. Larry Bucshon [R-IN]Rep. Bill Flores [R-TX]
Rep. Susan Brooks [R-IN]Sen. Markwayne Mullin [R-OK]Rep. Richard Hudson [R-NC]Rep. Earl Carter [R-GA]
Rep. Greg Gianforte [R-MT]Rep. Gary Palmer [R-AL]Rep. Tom Cole [R-OK]Rep. Roger Williams [R-TX]
Rep. Ralph Abraham [R-LA]Rep. Fred Keller [R-PA]Rep. John Rutherford [R-FL]Rep. Drew Ferguson [R-GA]
Rep. David Kustoff [R-TN]Rep. Denver Riggleman [R-VA]Rep. Bruce Westerman [R-AR]Rep. Garret Graves [R-LA]
Rep. Doug LaMalfa [R-CA]Rep. James Baird [R-IN]Rep. Bill Huizenga [R-MI]Rep. Greg Murphy [R-NC]
Rep. Michael Conaway [R-TX]Rep. Rick Allen [R-GA]Rep. Randy Weber [R-TX]Rep. Dan Newhouse [R-WA]
Rep. Brian Babin [R-TX]Rep. James Hagedorn [R-MN]Rep. David Rouzer [R-NC]Rep. Tom Rice [R-SC]
Rep. Joe Wilson [R-SC]Rep. Gregory Pence [R-IN]Rep. French Hill [R-AR]Sen. Roger Marshall [R-KS]
Rep. Troy Balderson [R-OH]Rep. Robert Aderholt [R-AL]Rep. Rodney Davis [R-IL]Rep. Paul Mitchell [R-MI]
Rep. Dan Crenshaw [R-TX]Rep. John Joyce [R-PA]Rep. Dusty Johnson [R-SD]Rep. Mark Green [R-TN]
Rep. Carol Miller [R-WV]Rep. Elise Stefanik [R-NY]Rep. Jim Banks [R-IN]Rep. James Comer [R-KY]
Rep. Michael McCaul [R-TX]Rep. Mario Diaz-Balart [R-FL]Rep. Mark Amodei [R-NV]Rep. Ralph Norman [R-SC]
Rep. David Roe [R-TN]Sen. Ted Budd [R-NC]Rep. Paul Cook [R-CA]Rep. Kevin Hern [R-OK]
Rep. Steve Chabot [R-OH]Rep. Greg Steube [R-FL]Rep. John Curtis [R-UT]Rep. Glenn Grothman [R-WI]
Rep. Bryan Steil [R-WI]Rep. David Joyce [R-OH]Rep. Christopher Smith [R-NJ]Rep. Anthony Gonzalez [R-OH]
Rep. Pete Stauber [R-MN]Rep. Vern Buchanan [R-FL]Rep. Adrian Smith [R-NE]Rep. Jody Arrington [R-TX]
Rep. Kenny Marchant [R-TX]Rep. Jackie Walorski [R-IN]Rep. Mike Kelly [R-PA]Rep. Jason Smith [R-MO]
Rep. Darin LaHood [R-IL]Rep. George Holding [R-NC]Rep. Ron Estes [R-KS]Rep. Tom Reed [R-NY]
Rep. David Schweikert [R-AZ]Rep. Brad Wenstrup [R-OH]Rep. Martha Roby [R-AL]Rep. Guy Reschenthaler [R-PA]
Rep. Will Hurd [R-TX]Rep. Steve Watkins [R-KS]Rep. Blaine Luetkemeyer [R-MO]Rep. Michael Turner [R-OH]
Rep. Glenn Thompson [R-PA]Rep. Jaime Herrera Beutler [R-WA]Rep. Michael Guest [R-MS]Rep. Vicky Hartzler [R-MO]
Rep. Ann Wagner [R-MO]Rep. Michael Waltz [R-FL]Rep. Ron Wright [R-TX]Rep. Bob Gibbs [R-OH]
Rep. Don Bacon [R-NE]Rep. Andy Harris [R-MD]Rep. Jeff Duncan [R-SC]Rep. Mike Bost [R-IL]
Rep. Garland Barr [R-KY]Rep. Daniel Webster [R-FL]Rep. Bradley Byrne [R-AL]Rep. John Moolenaar [R-MI]
Rep. Steve Womack [R-AR]Rep. Kay Granger [R-TX]Rep. Dan Meuser [R-PA]Rep. Harold Rogers [R-KY]
Rep. Neal Dunn [R-FL]Rep. John Katko [R-NY]Rep. Lloyd Smucker [R-PA]Rep. Peter King [R-NY]
Rep. Ross Spano [R-FL]Rep. Mac Thornberry [R-TX]Rep. Lee Zeldin [R-NY]Rep. Tim Burchett [R-TN]
Rep. Alexander Mooney [R-WV]Rep. Austin Scott [R-GA]Rep. John Carter [R-TX]Rep. Scott Perry [R-PA]
Rep. Jack Bergman [R-MI]Rep. Russ Fulcher [R-ID]Rep. Jody Hice [R-GA]Rep. Michael Simpson [R-ID]
Rep. Kelly Armstrong [R-ND]Rep. Scott DesJarlais [R-TN]Rep. William Timmons [R-SC]Rep. Lance Gooden [R-TX]
Rep. Dan Bishop [R-NC]Rep. Eric Crawford [R-AR]Rep. Robert Wittman [R-VA]Rep. Mo Brooks [R-AL]

History

DateChamberAction
2019-12-19HouseReferred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
2019-12-10HouseReferred to the Subcommittee on Health.
2019-12-09HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-09HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-09HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-09HouseIntroduced in House

Same As/Similar To

HB938 (Related) 2019-05-02 - Placed on the Union Calendar, Calendar No. 24.
HB965 (Related) 2019-05-16 - Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
HB1264 (Related) 2019-02-15 - Referred to the Subcommittee on Health.
HB1499 (Related) 2019-05-10 - Placed on the Union Calendar, Calendar No. 30.
HB1503 (Related) 2021-01-05 - Became Public Law No: 116-290.
HB1520 (Related) 2020-12-22 - Became Public Law No: 116-246. (TXT | PDF)
HB1781 (Related) 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB1922 (Related) 2020-12-18 - Placed on the Union Calendar, Calendar No. 559.
HB2087 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB2115 (Related) 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB2376 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB3029 (Related) 2019-06-04 - Subcommittee Hearings Held.
HB3408 (Related) 2019-06-24 - Referred to the Subcommittee on Health.
HB3415 (Related) 2019-06-24 - Referred to the Subcommittee on Health.
HB3443 (Related) 2019-07-24 - Sponsor introductory remarks on measure. (CR E971)
HB5281 (Related) 2019-12-04 - Referred to the Subcommittee on Health.
SB801 (Related) 2019-03-14 - Read twice and referred to the Committee on Finance.
SB1227 (Related) 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
SB1636 (Related) 2020-12-15 - Held at the desk.
SB1999 (Related) 2019-06-27 - Read twice and referred to the Committee on Finance.
SB2051 (Related) 2019-06-28 - Read twice and referred to the Committee on Finance.
SB2740 (Related) 2019-12-14 - Referred to the Subcommittee on Health.
SB3013 (Related) 2019-12-10 - Read twice and referred to the Committee on Finance.
HB5444 (Related) 2019-12-18 - Referred to the Subcommittee on Health.
HB5882 (Related) 2020-02-12 - Referred to the House Committee on Energy and Commerce.
HB6155 (Related) 2020-03-09 - Referred to the House Committee on Energy and Commerce.
HB4400 (Related) 2019-09-20 - Referred to the Subcommittee on Health.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3942 (Related) 2020-06-11 - Read twice and referred to the Committee on Finance.
HB7877 (Related) 2020-07-30 - Referred to the Subcommittee on Health.
HB7898 (Related) 2021-01-05 - Became Public Law No: 116-321.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.

Subjects

Administrative law and regulatory procedures
Administrative remedies
Advisory bodies
Appropriations
Biological and life sciences
Business records
Cancer
Chemistry
Child health
Civil actions and liability
Competition and antitrust
Congressional oversight
Consumer affairs
Corporate finance and management
Cosmetics and personal care
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Executive agency funding and structure
Federal Trade Commission (FTC)
Food and Drug Administration (FDA)
Fraud offenses and financial crimes
Genetics
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health information and medical records
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Home and outpatient care
Hospital care
Immunology and vaccination
Income tax deductions
Income tax exclusion
Inflation and prices
Intellectual property
Intergovernmental relations
Judicial review and appeals
Licensing and registrations
Manufacturing
Marketing and advertising
Medicaid
Medical education
Medical research
Medical tests and diagnostic methods
Medicare
Office of the U.S. Trade Representative
Prescription drugs
Product development and innovation
Public participation and lobbying
Research and development
Retail and wholesale trades
State and local government operations
Trade agreements and negotiations
User charges and fees
Women's health

US Congress State Sources


Bill Comments

feedback